BlackRock Fund Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $49.5M | Sell |
4,581,672
-276,603
| -6% | -$2.99M | 0.01% | 1696 |
|
|
2016
Q3 | $49.8M | Buy |
4,858,275
+354,655
| +8% | +$3.64M | 0.01% | 1581 |
|
|
2016
Q2 | $58.8M | Buy |
4,503,620
+2,548,007
| +130% | +$33.3M | 0.01% | 1386 |
|
|
2016
Q1 | $21.5M | Buy |
1,955,613
+19,760
| +1% | +$217K | 0.01% | 1950 |
|
|
2015
Q4 | $17.8M | Sell |
1,935,853
-106,317
| -5% | -$978K | ﹤0.01% | 2119 |
|
|
2015
Q3 | $14.2M | Buy |
2,042,170
+57,670
| +3% | +$400K | ﹤0.01% | 2207 |
|
|
2015
Q2 | $19.5M | Sell |
1,984,500
-122,432
| -6% | -$1.2M | ﹤0.01% | 2129 |
|
|
2015
Q1 | $18.7M | Buy |
2,106,932
+52,460
| +3% | +$465K | ﹤0.01% | 2114 |
|
|
2014
Q4 | $18M | Buy |
2,054,472
+172,422
| +9% | +$1.51M | ﹤0.01% | 2125 |
|
|
2014
Q3 | $13M | Sell |
1,882,050
-40,570
| -2% | -$280K | ﹤0.01% | 2205 |
|
|
2014
Q2 | $10.1M | Sell |
1,922,620
-263,431
| -12% | -$1.39M | ﹤0.01% | 2411 |
|
|
2014
Q1 | $9.95M | Buy |
2,186,051
+80,672
| +4% | +$367K | ﹤0.01% | 2402 |
|
|
2013
Q4 | $10.6M | Sell |
2,105,379
-24,559
| -1% | -$124K | ﹤0.01% | 2357 |
|
|
2013
Q3 | $10.8M | Buy |
2,129,938
+267,771
| +14% | +$1.36M | ﹤0.01% | 2312 |
|
|
2013
Q2 | $9.24M | Buy |
+1,862,167
| New | +$9.24M | ﹤0.01% | 2296 |
|